Trade Summary

1 week ago, Suvretta Capital Management, LLC, serving as Dir, 10% owner at Benitec Biopharma Inc. (BNTC), purchased 46,141 shares at $11.68 per share, for a total transaction value of $538,972.00. Following this transaction, Suvretta Capital Management, LLC now holds 1,826,653 shares of BNTC.

This purchase represents a 3.00% increase in Suvretta Capital Management, LLC's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, December 18, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 22, 2025, 4 days after the trade was made.

Benitec Biopharma Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.